Feasibility Trial of a Tailored Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer.

ABSTRACT:

Background

Adherence to cancer treatment protocol medications is critical for optimizing health outcomes, but up to 60% of adolescents and young adults (AYAs) with cancer miss doses. This randomized pilot trial evaluated the feasibility, usability, and acceptability of a tailored adherence-promotion intervention (Supporting Medication Management with Individualized Treatment, SUMMIT) for AYAs with cancer.

Methods

Seventy AYAs (ages 15-24 years) prescribed an oral chemotherapy or a prophylactic antimicrobial as part of their cancer treatment regimen enrolled in the trial. Of these, 24 met criteria for randomization and were assigned to the intervention (SUMMIT) or control (uniform standard of care) arm. Feasibility data were tracked prospectively. AYAs completed usability and

SUBMITTER: McGrady ME 

PROVIDER: S-EPMC12616667 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature